Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New cholesterol pill shows promise for taiwanese patients

NCT ID NCT06925100

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 36 times

Summary

This study looked at how well a cholesterol-lowering drug called bempedoic acid works in Taiwanese adults with high cholesterol. About 180 people took the drug for 12 weeks to see if it safely lowered their bad cholesterol (LDL-C) and helped them reach their cholesterol goals. The drug is already approved in the US and Europe, but this was the first test in a Taiwanese population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Far Eastern Memorial Hospital

    New Taipei City, 220, Taiwan

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, 807, Taiwan

  • Linkou Chang Gung Memorial Hospital

    Taoyuan, 333, Taiwan

Conditions

Explore the condition pages connected to this study.